← All trials
NCT01349062
Phase 3Interventional
Includes trials conducted after preliminary evidence suggesting effectiveness of the drug has been obtained, and are intended to gather additional information to evaluate the overall benefit-risk relationship of the drug.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 27, 2012
- Primary completion
- Feb 27, 2017
- Completion date
- Feb 27, 2017
- First posted
- —
- Last posted
- —
- Enrollment
- 1000
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Traditional Alternative Medicine Research, IndiaLead sponsor
- Traditional Alternative Medicine Research, IndiaOverall official - principal investigator
- Traditional Alternative Medicine Research, IndiaReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.